LOC441617 Inhibitors
SEE ALSO...
Items 11 to 20 of 21 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Anisomycin | 22862-76-6 | sc-3524 sc-3524A | 5 mg 50 mg | $99.00 $259.00 | 36 | |
Anisomycin is a potent activator of the JNK/SAPK signaling pathways. These pathways can phosphorylate and activate several proteins, potentially including LOC441617 if it is a target within these pathways. | ||||||
Spectinomycin dihydrochloride pentahydrate | 22189-32-8 | sc-203279 sc-203279A | 5 g 10 g | $84.00 $122.00 | 9 | |
This nitric oxide donor can lead to the activation of guanylyl cyclase and increased levels of cGMP, which may activate cGMP-dependent protein kinases (PKG). PKG can phosphorylate and activate proteins, potentially including LOC441617 if it is a substrate or is regulated by PKG pathways. | ||||||
Palbociclib | 571190-30-2 | sc-507366 | 50 mg | $321.00 | ||
CDK4/6 inhibitor that could lead to reduced LOC441617 activity by halting cell cycle progression, potentially affecting any cell cycle-dependent functions of LOC441617. | ||||||
Trametinib | 871700-17-3 | sc-364639 sc-364639A sc-364639B | 5 mg 10 mg 1 g | $114.00 $166.00 $947.00 | 19 | |
MEK inhibitor that could indirectly decrease LOC441617 activity by inhibiting the MAPK/ERK pathway, which may regulate LOC441617's function in cell proliferation and survival. | ||||||
Aluminum Fluoride | 7784-18-1 | sc-291881 sc-291881A | 10 g 50 g | $67.00 $250.00 | ||
AlF3 can act as a phosphate analog and activate heterotrimeric G-proteins, leading to activation of downstream signaling molecules which may include LOC441617 if it is part of G-protein-coupled pathways. | ||||||
SP600125 | 129-56-6 | sc-200635 sc-200635A | 10 mg 50 mg | $40.00 $150.00 | 257 | |
JNK inhibitor that could lead to the inhibition of LOC441617 if it interacts with or is regulated by the JNK signaling pathway involved in stress responses and apoptosis. | ||||||
Phorbol | 17673-25-5 | sc-253267 | 5 mg | $270.00 | 1 | |
4β-Phorbol is another activator of PKC. Upon activation of PKC, downstream proteins could be phosphorylated and activated, potentially including LOC441617 if it is part of PKC's signaling network. | ||||||
(−)-Epigallocatechin Gallate | 989-51-5 | sc-200802 sc-200802A sc-200802B sc-200802C sc-200802D sc-200802E | 10 mg 50 mg 100 mg 500 mg 1 g 10 g | $43.00 $73.00 $126.00 $243.00 $530.00 $1259.00 | 11 | |
EGCG can inhibit phosphodiesterases, leading to increased cAMP and activation of cAMP-dependent PKA. PKA may phosphorylate and activate proteins, potentially including LOC441617 if it is regulated by PKA signaling. | ||||||
SB 203580 | 152121-47-6 | sc-3533 sc-3533A | 1 mg 5 mg | $90.00 $349.00 | 284 | |
p38 MAPK inhibitor that might reduce LOC441617 activity by inhibiting p38 MAPK, affecting stress responses and inflammatory signaling that could regulate LOC441617. | ||||||
Calyculin A | 101932-71-2 | sc-24000 sc-24000A | 10 µg 100 µg | $163.00 $800.00 | 59 | |
As an inhibitor of protein phosphatases PP1 and PP2A, Calyculin A can result in increased phosphorylation levels of proteins by preventing their dephosphorylation. This could lead to the maintained activation of proteins, possibly including LOC441617 if it is normally regulated by PP1 or PP2A. | ||||||